Medicare IVIG denied: how to appeal

Quick answer

If Medicare (Original + Advantage) denied your IVIG and immunoglobulin, you can appeal, and the plan must give you its file and the criteria it used. Filing windows by plan type: 120 days from the notice (Original Medicare); 65 days from the notice (Medicare Advantage); 65 days from the notice (Part D). The date printed on your denial notice controls; it can only be later than these floors, never earlier.

Why Medicare (Original + Advantage) denies IVIG and immunoglobulin

Medicare is a federal program with two delivery modes, Original (fee-for-service Part A/B + Part D drug plans) and Advantage (private MA-C plans). Each has its own appeal ladder, and rights are stronger than most beneficiaries realize.

For IVIG and immunoglobulin specifically: Intravenous and subcutaneous immunoglobulin (IVIG, SCIG) is expensive, infused repeatedly, and reviewed against a short list of accepted diagnoses. Denials say 'not medically necessary' or 'experimental' for the specific condition, or move the drug to a different benefit or site of care.

The law that controls this appeal

Plans compare the diagnosis to their immunoglobulin policy, which typically lists FDA-labeled indications (primary immunodeficiency, immune thrombocytopenia, chronic inflammatory demyelinating polyneuropathy, multifocal motor neuropathy, Kawasaki disease, and others) and selected off-label uses supported by published evidence. Medicare Part B covers immunoglobulin for primary immunodeficiency at home under 42 CFR 410.10 and the home IVIG benefit; other indications follow local coverage determinations in the Medicare Coverage Database. Plan criteria must be disclosed on request.

Note for Medicare (Original + Advantage): where the standard above cites ERISA or the ACA appeal rules, those describe employer and Marketplace plans. The windows and levels that apply to Medicare (Original + Advantage) are in the table below.

At a glance

Medicare (Original + Advantage) appeals: the rule, the deadline and the next level, by plan type

Original Medicare, Medicare Advantage and Part D each have their own federal ladder. The notice you received says which one you are in.

Plan type	Rule that governs	File your appeal within	The plan must answer	If the plan says no again
Original Medicare (Parts A and B) Fee-for-service Medicare. The Medicare Summary Notice lists the denial.	42 CFR Part 405, Subpart I.	Redetermination: 120 days from receipt of the initial determination (42 CFR 405.942). Reconsideration by a Qualified Independent Contractor: 180 days from the redetermination (§ 405.962). ALJ hearing: 60 days (§ 405.1002).	The Medicare Administrative Contractor decides a redetermination within 60 days (§ 405.950); the QIC decides within 60 days (§ 405.970).	QIC reconsideration, ALJ hearing (amount-in-controversy threshold), Medicare Appeals Council, federal district court. Fast-track appeals of service terminations go to the Quality Improvement Organization (42 CFR 405.1200 to 405.1206).
Medicare Advantage (Part C) A private plan that replaces Original Medicare. The card says Medicare Advantage, HMO, PPO or PFFS.	42 CFR Part 422, Subpart M (§§ 422.560 to 422.634). Coverage decisions must follow Original Medicare rules (42 CFR 422.101).	65 calendar days from the date on the denial notice to request the plan's reconsideration (42 CFR 422.582, as amended effective 1 January 2025).	Expedited: 72 hours. Standard pre-service: 30 days (7 days for Part B drugs). Payment: 60 days (42 CFR 422.590).	If the plan does not fully reverse itself it must send the case to the Independent Review Entity on its own (42 CFR 422.592); then an ALJ hearing when the amount in controversy meets the annual threshold, the Medicare Appeals Council and federal court. State external review does not apply.
Medicare Part D (drug plan or MA-PD) A stand-alone drug plan or the drug benefit inside a Medicare Advantage plan.	42 CFR Part 423, Subpart M; exceptions under 42 CFR 423.578.	65 calendar days from the date on the notice to request a redetermination (42 CFR 423.582, as amended effective 1 January 2025). Formulary, tiering and step-therapy exceptions need the prescriber's supporting statement (§ 423.578).	Redetermination: 7 calendar days standard, 72 hours expedited (42 CFR 423.590). Coverage determinations: 72 hours standard, 24 hours expedited, once the prescriber's statement is received (§§ 423.568, 423.572).	Independent Review Entity reconsideration on your request within 65 days of the redetermination notice (§ 423.600); then ALJ, Council and court.

Original Medicare (Parts A and B)

What you can demand. Follow the appeal instructions on the Medicare Summary Notice or use form CMS-20027. Your provider can appeal for you; any other representative needs form CMS-1696.

How to open the appeal. Cite 42 CFR 405.942 and the coverage rule that applies (the national or local coverage determination), and attach the treating clinician's statement addressed to each coverage criterion.

Medicare Advantage (Part C)

What you can demand. The plan may not apply internal criteria that are more restrictive than Medicare's national and local coverage determinations, and must decide medical necessity on your individual circumstances (42 CFR 422.101(b), (c)). You can ask for the case file and the criteria used.

How to open the appeal. Cite 42 CFR 422.582 and 422.101(c): the plan must decide on your individual circumstances under Medicare coverage rules, and must forward an unfavorable reconsideration to the IRE itself.

Medicare Part D (drug plan or MA-PD)

What you can demand. The exception turns on the prescriber's statement that the formulary alternative would be less effective or would harm you (42 CFR 423.578(b)(5)).

How to open the appeal. Cite 42 CFR 423.578 and 423.582 and attach the prescriber's supporting statement written to the exception standard.

Primary sources for this table

Windows are federal floors or the rule as written; the denial notice controls. Reviewed 13 September 2026. General information, not legal advice; Apellica is not a law firm.

What Medicare (Original + Advantage) denies for IVIG and immunoglobulin

The IVIG and immunoglobulin services most often denied:

IVIG for CIDP, myasthenia gravis, dermatomyositis, or autoimmune encephalitis
Continuation after the initial authorization period when response is not documented
Dose or frequency above the policy's stated range
Site-of-care changes: hospital outpatient infusion moved to home or a standalone center
Subcutaneous immunoglobulin when the plan prefers intravenous

Why IVIG and immunoglobulin claims get denied

A typical Medicare (Original + Advantage) IVIG and immunoglobulin denial almost always cites one of these reasons. Each one maps to a specific rebuttal in the appeal:

Diagnosis not on the plan's list of covered indications
Required baseline labs (immunoglobulin levels, vaccine response, nerve conduction studies) not in the record
No documented failure of first-line therapy where the policy requires it
Response to prior IVIG cycles not documented in measurable terms
Plan classifies the use as experimental or investigational

The Medicare (Original + Advantage) appeal process

Appeal levels: 5 federal levels. Each has its own deadline; the ALJ and court levels require the amount in controversy to meet the annual threshold CMS publishes.

Carrier timing: 120 days from the notice for level 1 in Original Medicare (redetermination) or 65 days for Medicare Advantage reconsideration (42 CFR 422.582). Later levels: 180 days for the QIC reconsideration in Original Medicare, then 60 days each.

IVIG timing for Medicare (Original + Advantage): the filing windows and decision clocks in the table above apply; the date on the notice controls.

What we know about Medicare (Original + Advantage): Medicare cases require a CMS-1696 Appointment of Representative form for us to act on your behalf. We provide this at intake.

Common Medicare (Original + Advantage) denial patterns for IVIG and immunoglobulin

Original Medicare: 5-level appeal. Redetermination by MAC → reconsideration by QIC → ALJ hearing → Medicare Appeals Council → federal district court. The QIC and ALJ levels reverse a substantial share of denials when properly briefed.
Medicare Advantage: identical 5-level ladder. MA plans must follow the same federal appeal structure as Original Medicare. Plan-level reconsideration → Independent Review Entity (Maximus) → ALJ → Council → federal court.
Part D drug coverage denials. Part D appeals follow a separate but parallel ladder. Tiering exceptions and formulary exceptions are filed before a coverage determination challenge.

How to win your Medicare (Original + Advantage) IVIG and immunoglobulin appeal

Strategy for IVIG and immunoglobulin: Request the plan's immunoglobulin policy and the reviewer's specialty. Have the treating specialist write to each criterion: diagnosis with supporting labs or electrodiagnostic studies, prior therapies and results, measurable response to IVIG, and dosing rationale. For off-label uses, attach the guideline or peer-reviewed evidence the specialist relies on and identify it accurately. If the denial is 'experimental', the external review process specifically covers that determination.

Filed against Medicare (Original + Advantage), that strategy rides on this procedural spine:

Procedural-rights anchor. Cite 42 CFR 405.942 and the coverage rule that applies (the national or local coverage determination), and attach the treating clinician's statement addressed to each coverage criterion. If your Medicare (Original + Advantage) coverage is a different plan type (Medicare Advantage, Medicare Part D), use that row of the table above instead; the rule and the deadline change with the plan, not the carrier.
Criteria-disclosure demand. Medicare (Original + Advantage) frequently denies on "not medically necessary" without disclosing the clinical criteria applied. Once disclosed, those criteria become the rebuttal map.
Controlling-standard citation. Plans compare the diagnosis to their immunoglobulin policy, which typically lists FDA-labeled indications (primary immunodeficiency, immune thrombocytopenia, chronic inflammatory demyelinating polyneuropathy, multifocal motor neuropathy, Kawasaki disease, and others) and selected off-label uses supported by published evidence. Medicare Part B covers immunoglobulin for primary immunodeficiency at home under 42 CFR 410.10 and the home IVIG benefit; other indications follow local coverage determinations in the Medicare Coverage Database. Plan criteria must be disclosed on request.
Treating-provider attestation. A letter from the treating physician addressing each criterion in Medicare (Original + Advantage)'s own policy language. This is the single strongest evidentiary element.
Requested action. A specific demand to reverse the IVIG and immunoglobulin denial and approve the service, not a general "please reconsider."

Documents you'll need for your Medicare (Original + Advantage) IVIG and immunoglobulin appeal

The denial letter naming the criterion or policy applied
Specialist's notes with diagnosis, labs, and electrodiagnostic or imaging results
Record of prior therapies and outcomes
Infusion records showing dose, frequency, and documented response
The plan's immunoglobulin policy (request it in writing)

What a IVIG and immunoglobulin appeal can recover

Typical recovery for IVIG and immunoglobulin cases runs Immunoglobulin is among the most expensive recurring therapies; a denied course commonly represents thousands of dollars per infusion in billed charges.. The exact figure depends on the specific service and your plan's contracted rates.

Medicare (Original + Advantage) IVIG and immunoglobulin appeals: frequently asked questions

My infusions are scheduled this week. What do I do first?

Ask for an expedited appeal in writing and have the prescriber confirm that delay could seriously jeopardize health. Expedited decisions are due within 72 hours.

Medicare (Original + Advantage) approved IVIG before. Why is it denied now?

Continuation reviews look for measurable response. If the record only says 'doing well', the plan may treat that as no evidence. The specialist's note should record the objective measures the policy asks for.

Does Medicare (Original + Advantage) have to tell me which policy it used?

For employer and ACA plans, yes: the internal rule, guideline, or protocol relied on must be provided free on request. Ask for it by name in the appeal.

What Apellica does for Medicare (Original + Advantage) IVIG and immunoglobulin appeals

We file appeals against Medicare (Original + Advantage) specifically configured to its internal review process. Every IVIG and immunoglobulin appeal embeds the criteria-disclosure demand, the procedural-rights anchor, the controlling-standard citation above, treating-provider attestation language, and the peer-reviewed evidence relevant to the denied service.

Cost: $0 upfront. We work on contingency for Medicare (Original + Advantage) appeals, if the appeal succeeds, we collect a percentage of the recovered claim value. If it fails, you owe nothing.

Start your Medicare (Original + Advantage) IVIG and immunoglobulin appeal

Submit a 2-minute intake. A senior reviewer responds within one business day with the specific appeal strategy for your case.

Start free appeal review →

Medicare (Original + Advantage) denied your IVIG and immunoglobulin? Here is what to do next